文献速递心律失常

系统性炎症:尖端扭转型室速患者的新型QT延长风险因素

Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes.
PubMed 文献 · Heart · 2017-05-10

研究纳入40例尖端扭转型室速(TdP)患者,发现80%患者C反应蛋白(CRP)升高,白介素-6(IL-6)较对照升高约15-20倍;另46例炎症性疾病患者经治疗后CRP下降>75%时,校正QT(QTc)显著缩短-22.3 ms。提示系统性炎症可能通过IL-6升高延长QT,成为TdP的新型风险因素。

要点

  • TdP患者中80% CRP升高,中位数约3 mg/dL,18/40可识别明确炎症性疾病。
  • TdP患者IL-6较对照升高约15-20倍,与类风湿关节炎患者相当,TNFα和IL-1未升高。
  • 炎症性疾病患者CRP下降>75%后,IL-6降低且QTc显著缩短-22.3 ms。

核心结论

  • 系统性炎症可能通过IL-6升高延长QT,在其他经典风险因素存在时促成TdP发生;若被证实,或为抗心律失常治疗开辟新途径。

研究设计与样本

  • 连续纳入40例发生TdP的患者(TdP队列),比较其CRP和促炎细胞因子与活动性类风湿关节炎、合并症或健康对照。
  • 前瞻性纳入46例不同炎症性疾病且CRP升高的患者(炎症队列),在疾病活动期及治疗后CRP下降>75%后测量QTc和细胞因子。

主要发现

  • TdP队列中80%患者CRP升高,中位数约3 mg/dL,18/40例可识别明确炎症性疾病(急性感染12例、免疫介导疾病5例、其他1例)。
  • TdP患者IL-6较对照升高约15-20倍,与类风湿关节炎患者相当;TNFα和IL-1未见升高。
  • 炎症队列QTc延长常见(均值456.6±30.9 ms),CRP下降与IL-6水平降低及QTc显著缩短-22.3 ms相关。

关键数值与推荐

  • TdP队列CRP升高者占80%,中位数约3 mg/dL。
  • TdP患者IL-6较对照升高约15-20倍。
  • 炎症队列QTc均值456.6±30.9 ms;治疗后CRP下降>75%时QTc缩短-22.3 ms。

临床怎么用

  • 在TdP患者中可关注系统性炎症及IL-6水平,作为经典风险因素之外的潜在QT延长因素。
  • 对合并炎症性疾病的患者,治疗使CRP下降>75%后可能伴随QTc缩短。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Increasing evidence indicates systemic inflammation as a new potential cause of acquired long QT syndrome (LQTS), via cytokine-mediated changes in cardiomyocyte ion channels. Torsade de pointes (TdP) is a life-threatening polymorphic ventricular tachycardia occurring in patients with LQTS, usually when multiple QT-prolonging factors are simultaneously present. Since classical risk factors cannot fully explain TdP events in a number of patients, we hypothesised that systemic inflammation may represent a currently overlooked risk factor contributing to TdP development in the general population. METHODS: Forty consecutive patients who experienced TdP (TdP cohort) were consecutively enrolled and circulating levels of C-reactive protein (CRP) and proinflammatory cytokines (interleukin-6 (IL-6), tumour necrosis factor alpha (TNFα), interleukin-1 (IL-1)) were compared with patients with active rheumatoid arthritis (RA), comorbidity or healthy controls. An additional 46 patients with different inflammatory conditions (acute infections, n=31; immune-mediated diseases, n=12; others, n=3) and elevated CRP (inflammatory cohort) were prospectively enrolled, and corrected QT (QTc) and cytokine levels were measured during active disease and after a CRP decrease of >75% subsequent to therapy. RESULTS: In the TdP cohort, 80% of patients showed elevated CRP levels (median: ~3 mg/dL), with a definite inflammatory disease identifiable in 18/40 cases (acute infections, n=12; immune-mediated diseases, n=5; others, n=1). In these subjects, IL-6, but not TNFα and IL-1, was ~15-20 times higher than in controls, and comparable to RA patients. In the inflammatory cohort, where QTc prolongation was common (mean values: 456.6±30.9 ms), CRP reduction was associated with IL-6 level decrease and significant QTc shortening (-22.3 ms). CONCLUSION: The data are first to show that systemic inflammation via elevated IL-6 levels may represent a novel QT-prolonging risk factor contributing to TdP occurrence in the presence of other classical risk factors. If confirmed, this could open new avenues in antiarrhythmic therapy.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Lazzerini PE, Laghi-Pasini F, Bertolozzi I, et al. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes. Heart. 2017. PMID: 28490617. doi:10.1136/heartjnl-2016-311079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。